NCT04261972View on ClinicalTrials.gov

Cell-free DNA in Hereditary And High-Risk Malignancies

Active, not recruitingOBSERVATIONAL
Enrollment

1,416

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Hereditary Cancer Syndrome
Interventions
GENETIC

Next generation sequencing (NGS)

NGS

Trial Locations (7)

V5Z 4E6

BC Cancer Agency, Vancouver

A1B 3V6

Eastern Health, St. John's

B3K 6R8

IWK Health Centre, Halifax

M5G 1X5

Sinai Health System, Toronto

M5G 2M9

University Health Network, Toronto

M5S 1B2

Women's College Hospital, Toronto

H3T 1E2

Jewish General Hospital, Montreal

Sponsors
All Listed Sponsors
collaborator

Sinai Health System

OTHER

collaborator

Women's College Hospital

OTHER

collaborator

Jewish General Hospital

OTHER

collaborator

IWK Health Centre

OTHER

collaborator

Eastern Health

OTHER

collaborator

BC Cancer

UNKNOWN

lead

University Health Network, Toronto

OTHER